Table 2.
Pre-existing medical conditions, concomitant medication as well as symptoms, and laboratory and radiological findings at SARS-CoV-2 diagnosis.
| Medical History | N = 101 |
|---|---|
| Pre-existing illnesses a | |
| None | 54 (53) |
| Mild | 27 (27) |
| Moderate | 13 (13) |
| Severe | 2 (2) |
| Pre-existing conditions | |
| Hypertension | 3 (3) |
| Diabetes | |
| Diabetes mellitus Type I | 1 (1) |
| Diabetes mellitus Type II | 3 (3) |
| Gestational Diabetes | 16 (16) |
| Thyroid Disease | |
| Hypothyroidism | 5 (5) |
| Asthma | 4 (4) |
| Hepatitis B | 3 (3) |
| Others | 5 (5) |
| Concomitant Medication | |
| None | 63 (62) |
| Antibiotics | 6 (6) |
| Acetylsalicylic Acid | 3 (3) |
| Other NSAIDs | 2 (2) |
| Immunosuppressive Drugs | 1 (1) |
| Antihypertensive Drugs | 5 (5) |
| Asthma Medication | 1 (1) |
| Antidiabetic Drugs | 10 (10) |
| Heparin derivative | 11 (11) |
| Important Others | 3 (3) |
| COVID-19 | |
| Symptoms b | n = 99 (98) |
| Number of symptoms per patient | 6 (±3) |
| Cough | 79 (78) |
| Dyspnea | 84 (83) |
| Malaise | 77 (76) |
| Fever | 70 (69) |
| Fatigue | 57 (56) |
| Clinical examination—diagnostic Imaging | |
| Imaging | n = 45 (45) |
| Ultrasound examination of the lungs | 5 (11) |
| Thoracic X-ray | 31 (69) |
| Thoracic CAT-Scan | 14 (31) |
| Thoracic MRI | 2 (4) |
| Radiological Findings typical for COVID-19 | 41 (91) |
N (n%), mean (±SD), median (IQR); severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19), nonsteroidal anti-inflammatory drug (NSAID), computed tomography scan (CT-Scan), magnetic resonance imaging (MRI). a Pre-existing comorbidities were scored by the treating physician and categorized in the registry. Mild disease was defined as pre-existing illnesses without any medical impairments, moderate disease as disease with mild dysfunctions and need for regular medication intake, and severe disease as requiring regular medical attention. b Five most frequently reported symptoms displayed.